Atlas Trials

Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia

Clinical trial NCT00694707 · COMPLETED

Trial details

NCT number
NCT00694707
Sponsor
Forest Laboratories
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2008-06-30
Primary completion
2009-08-31
Enrollment
732

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.